Photo from archive.org
Type 2 diabetes is a major health problem placing increasing demands on healthcare systems. Our objective was to estimate healthcare resource use and related financial costs following treatment with exenatide‐based… Click to show full abstract
Type 2 diabetes is a major health problem placing increasing demands on healthcare systems. Our objective was to estimate healthcare resource use and related financial costs following treatment with exenatide‐based regimens prescribed as once‐weekly (EQW) or twice‐daily (EBID) formulations, compared with regimens based on basal insulin (BI).
Keywords:
resource utilization;
healthcare resource;
related financial;
basal insulin;
financial costs
Journal Title: Diabetes
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!